- Home
- BR vs SNN Comparison
BR vs SNN Comparison
Compare BR & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BR | SNN |
|---|---|---|
| Founded | 1962 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Business Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6B | 14.3B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | BR | SNN |
|---|---|---|
| Price | $153.27 | $29.77 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | ★ $246.17 | $36.25 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 04-30-2026 | 03-16-2026 |
| Dividend Yield | 2.43% | ★ 2.48% |
| EPS Growth | ★ 21.16 | N/A |
| EPS | ★ 6.18 | N/A |
| Revenue | ★ $4,142,600,000.00 | N/A |
| Revenue This Year | $10.04 | $8.58 |
| Revenue Next Year | $4.46 | $5.60 |
| P/E Ratio | ★ $24.19 | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $139.79 | $28.40 |
| 52 Week High | $271.91 | $38.79 |
Technical Indicators
Market Signals| Indicator | BR | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 52.33 | 39.57 |
| Support Level | $149.58 | $29.08 |
| Resistance Level | $165.18 | $33.89 |
| Average True Range (ATR) | 4.29 | 0.50 |
| MACD | 0.94 | 0.06 |
| Stochastic Oscillator | 95.35 | 34.06 |
Price Performance
Historical ComparisonAbout BR Broadridge Financial Solutions Inc.
Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communication and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two operating segments: investor communication solutions and global technology and operations.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.